Aerie Pharmaceuticals (United States)

Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2)

Janet B. Serle, L. Jay Katz, Eugene McLaurin et al. · American Journal of Ophthalmology · 2017 · 260 citations · Full text

A*Prune: an algorithm for finding K shortest paths subject to multiple constraints

Gang Liu, K. G. Ramakrishnan · 2002 · 184 citations

Mathematical Programming, Engineering, Network Routing +22

Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma

Cheng‐Wen Lin, Bryan W. Sherman, Lori Moore et al. · Journal of Ocular Pharmacology and Therapeutics · 2017 · 181 citations · Full text

Netarsudil Increases Outflow Facility in Human Eyes Through Multiple Mechanisms

Ruiyi Ren, Guorong Li, Thuy Duong Le et al. · Investigative Ophthalmology & Visual Science · 2016 · 155 citations · Full text

Double-masked, Randomized, Dose–Response Study of AR-13324 versus Latanoprost in Patients with Elevated Intraocular Pressure

Jason Bacharach, Harvey Dubiner, Brian Levy et al. · Ophthalmology · 2014 · 151 citations

Elevated Intraocular Pressure, Hypertension, Ocular Disease +7